Home/Filings/4/0001193125-26-018131
4//SEC Filing

Badawi David 4

Accession 0001193125-26-018131

CIK 0001531177other

Filed

Jan 20, 7:00 PM ET

Accepted

Jan 21, 4:56 PM ET

Size

5.6 KB

Accession

0001193125-26-018131

Research Summary

AI-generated summary of this filing

Updated

Sight Sciences (SGHT) CTO David Badawi Sells 4,836 Shares

What Happened
David Badawi, Chief Technology Officer and Director of Sight Sciences (SGHT), sold 4,836 shares of common stock on 2026-01-16. The shares were disposed for a total of approximately $32,014, at a weighted average price of $6.62 (individual sale prices ranged $6.44–$6.69). The sale was made to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units (RSUs).

Key Details

  • Transaction date: January 16, 2026. Filing date: January 21, 2026 (appears to be one business day after the usual two-business-day Form 4 deadline).
  • Transaction type/code: Sale (S); disposition to cover tax withholding related to RSU vesting (footnote F1 / tax withholding).
  • Price: Weighted average $6.62; individual sales ranged from $6.44 to $6.69 (footnote F2). The filer can provide a per-price breakdown on request.
  • Shares sold: 4,836 for ~$32,014 total.
  • Shares owned after transaction: 1,774,250 shares of common stock, plus 138,023 RSUs that have not yet vested and will be acquired upon vesting (footnote F3).
  • Footnotes: F1 = sale to cover tax liability on vested RSUs; F2 = price range and availability of detailed breakdown; F3 = current share and unvested RSU totals.

Context
This was a routine tax-withholding sale tied to RSU vesting, not a discretionary open-market sell signal about company operations. Such transactions are common when insiders satisfy withholding obligations and do not necessarily reflect a change in insider sentiment.

Insider Transaction Report

Form 4
Period: 2026-01-16
Badawi David
DirectorChief Technology Officer
Transactions
  • Sale

    Common Stock

    [F1][F2][F3]
    2026-01-16$6.62/sh4,836$32,0141,912,273 total
Footnotes (3)
  • [F1]Reflects shares of the Issuer's common stock, par value $0.001 per share ("common stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units.
  • [F2]Reflects the weighted average price at which the shares of common stock were sold. The shares were sold in multiple transactions at prices ranging from $6.44 to $6.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]Includes (i) 1,774,250 shares of common stock, and (ii) 138,023 shares of common stock which shall be acquired upon the vesting and settlement of restricted stock units ("RSUs") that have not yet vested.
Signature
/s/Jeremy Hayden, Attorney-in-Fact for David Badawi|2026-01-21

Documents

1 file

Issuer

Sight Sciences, Inc.

CIK 0001531177

Entity typeother

Related Parties

1
  • filerCIK 0001870825

Filing Metadata

Form type
4
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 4:56 PM ET
Size
5.6 KB